Teachers Advisors LLC Boosts Stake in Oxford Immunotec Global PLC (OXFD)

Teachers Advisors LLC raised its position in shares of Oxford Immunotec Global PLC (NASDAQ:OXFD) by 15.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 46,200 shares of the company’s stock after purchasing an additional 6,268 shares during the quarter. Teachers Advisors LLC owned 0.20% of Oxford Immunotec Global PLC worth $716,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of OXFD. Nationwide Fund Advisors grew its stake in Oxford Immunotec Global PLC by 1.9% during the 1st quarter. Nationwide Fund Advisors now owns 13,765 shares of the company’s stock valued at $213,000 after purchasing an additional 254 shares during the last quarter. Russell Investments Group Ltd. purchased a new stake in Oxford Immunotec Global PLC during the 1st quarter valued at about $1,135,000. Wells Fargo & Company MN grew its stake in Oxford Immunotec Global PLC by 129.2% during the 1st quarter. Wells Fargo & Company MN now owns 65,937 shares of the company’s stock valued at $1,021,000 after purchasing an additional 37,163 shares during the last quarter. Parkwood LLC purchased a new stake in Oxford Immunotec Global PLC during the 1st quarter valued at about $176,000. Finally, Denver Investment Advisors LLC grew its stake in Oxford Immunotec Global PLC by 47.5% during the 1st quarter. Denver Investment Advisors LLC now owns 30,880 shares of the company’s stock valued at $478,000 after purchasing an additional 9,949 shares during the last quarter. Institutional investors and hedge funds own 79.13% of the company’s stock.

Oxford Immunotec Global PLC (NASDAQ:OXFD) opened at 15.80 on Friday. Oxford Immunotec Global PLC has a one year low of $11.71 and a one year high of $19.51. The firm’s market cap is $364.60 million. The stock has a 50 day moving average price of $16.10 and a 200 day moving average price of $15.51.

Oxford Immunotec Global PLC (NASDAQ:OXFD) last released its quarterly earnings results on Tuesday, August 1st. The company reported ($0.32) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.32). Oxford Immunotec Global PLC had a negative return on equity of 35.76% and a negative net margin of 34.58%. The firm had revenue of $26.10 million for the quarter, compared to analyst estimates of $25.05 million. During the same quarter last year, the company posted ($0.29) earnings per share. The business’s revenue was up 35.9% on a year-over-year basis. Equities research analysts expect that Oxford Immunotec Global PLC will post ($1.63) EPS for the current year.

Several brokerages have recently issued reports on OXFD. Cowen and Company decreased their price objective on Oxford Immunotec Global PLC from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Thursday, August 17th. Zacks Investment Research cut Oxford Immunotec Global PLC from a “hold” rating to a “sell” rating in a report on Saturday, August 5th. Piper Jaffray Companies reissued a “buy” rating and issued a $26.00 price objective on shares of Oxford Immunotec Global PLC in a report on Thursday, August 3rd. Finally, ValuEngine raised Oxford Immunotec Global PLC from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $20.25.

In other Oxford Immunotec Global PLC news, Director Richard A. Sandberg sold 3,000 shares of Oxford Immunotec Global PLC stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $15.82, for a total value of $47,460.00. Following the sale, the director now owns 18,000 shares of the company’s stock, valued at approximately $284,760. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Peter Edwardson sold 22,371 shares of Oxford Immunotec Global PLC stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $17.70, for a total value of $395,966.70. Following the completion of the sale, the chief operating officer now directly owns 102,644 shares in the company, valued at approximately $1,816,798.80. The disclosure for this sale can be found here. Insiders sold a total of 125,110 shares of company stock worth $2,059,827 in the last ninety days. 7.58% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: “Teachers Advisors LLC Boosts Stake in Oxford Immunotec Global PLC (OXFD)” was originally published by BBNS and is the sole property of of BBNS. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at https://baseballnewssource.com/markets/teachers-advisors-llc-buys-6268-shares-of-oxford-immunotec-global-plc-oxfd/1592228.html.

Oxford Immunotec Global PLC Profile

Oxford Immunotec Global PLC is a diagnostics company. The Company is focused on developing and commercializing tests for under-served immune-regulated conditions. The Company’s product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology.

Institutional Ownership by Quarter for Oxford Immunotec Global PLC (NASDAQ:OXFD)

Receive News & Ratings for Oxford Immunotec Global PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Immunotec Global PLC and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.